Jiangsu Aidea Pharmaceutical Co (SHSE:688488) YoY Rev. per Sh. Growth : 147.80% (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Aidea Pharmaceutical Co YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Jiangsu Aidea Pharmaceutical Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was 147.80%.

Jiangsu Aidea Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2025 was ¥0.51.

Jiangsu Aidea Pharmaceutical Co YoY Rev. per Sh. Growth Historical Data

The historical data trend for Jiangsu Aidea Pharmaceutical Co's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Aidea Pharmaceutical Co YoY Rev. per Sh. Growth Chart

Jiangsu Aidea Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-21.24

-17.88

-1.17

64.92

3.39

Jiangsu Aidea Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															-26.26	4.41	58.71	44.40	147.80

Jiangsu Aidea Pharmaceutical Co YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Jiangsu Aidea Pharmaceutical Co's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2024 )
=	(Revenue per Share (A: Dec. 2024 )	-	Revenue per Share (A: Dec. 2023 ))	/	\| Revenue per Share (A: Dec. 2023 ) \|
=	(1.006	-	0.973)	/	\| 0.973 \|
=	3.39 %

Jiangsu Aidea Pharmaceutical Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=	(Revenue per Share (Q: Mar. 2025 )	-	Revenue per Share (Q: Mar. 2024 ))	/	\| Revenue per Share (Q: Mar. 2024 )) \|
=	(0.508	-	0.205)	/	\| 0.205 \|
=	147.80 %

Jiangsu Aidea Pharmaceutical Co YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Jiangsu Aidea Pharmaceutical Co's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Aidea Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Aidea Pharmaceutical Co Ltd (SHSE:688488) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2 Liuzhuang Road, Hanjiang District, Jiangsu Province, Yangzhou, CHN, 225008

Website

http://www.aidea.com.cn

Jiangsu Aidea Pharmaceutical Co Ltd produces and sells human-derived protein products, and also develops some generic drug businesses and distributes Abbott's HIV diagnostic equipment and reagents. The company focuses on development of new chemical entities of anti-tumor, anti-virus and cardiovascular areas, among which two NCE drugs for the treatment of Cancer and AIDS have been approved.

Executives

Wang Jun	Directors, senior managers
Fu He Liang	Director, core technical staff
Zhang Jie	Directors, senior managers
Yuan Yu	Core technical personnel
Su Gu Fang	Core technical personnel
Zhang Ji Bing	Core technical personnel
Wang Guang Rong	Directors, senior managers
Yu Ke	Directors, senior managers

Jiangsu Aidea Pharmaceutical Co Headlines

No Headlines